Acne Vulgaris

  title={Acne Vulgaris},
  author={Andrea L Zaenglein},
  journal={The New England Journal of Medicine},
  • Andrea L Zaenglein
  • Published 4 October 2018
  • Medicine, Biology
  • The New England Journal of Medicine
Acne VulgarisThe negative psychological effect of acne vulgaris can be profound and long‐lasting.Combination therapy with a retinoid and a benzoyl peroxide–containing antimicrobial agent is used to control mild‐to‐severe inflammatory acne.For moderate‐to‐severe cases, an oral antibiotic agent is also recommended, with the duration of use being typically limited to 3 to 4 months. Once clinical improvement occurs, acne control is maintained with a topical retinoid. Benzoyl peroxide may also be… 

Figures and Tables from this paper

Management of Acne Vulgaris: A Review.

Isotretinoin is approved by the US Food and Drug Administration for treating severe recalcitrant nodular acne but is often used to treat resistant or persistent moderate to severe acne, as well as acne that produces scarring or significant psychosocial distress.

The Role of Herbal Medicine in the Treatment of Acne Vulgaris: A Systematic Review of Clinical Trials

Evidence is provided that medicinal plants and phytochemicals are promising treatments for mild to moderate acne vulgaris, however, more quality of evidence and standardized methodologies are needed to support their effectiveness and safety claims.

Serum Vitamin D Levels at Different Stages of Acne Vulgaris Patients Treated with Isotretinoin: A Prospective Study

Clinically, AV is characterized by open-and-closed comedones, papules, pustules, and nodules; however, its emergence may be delayed until 25 to 30 years of age; the time at which AV fades varies.

Acne Vulgaris: A Patient and Physician’s Experience

In this article, the first coauthor, a young woman with acne vulgaris, shares her experience with the condition; she not only describes the clinical presentation and the eventual successful treatment

Efficacy and safety of oral silymarin in comparison with oral doxycycline and their combination therapy in the treatment of acne vulgaris

The results of this study suggest that although the silymarin monotherapy is not as effective as doxycycline for the treatment of acne vulgaris, it can be a therapeutic option.

The Effects of Once-Daily Tretinoin 0.05% Lotion on Quality of Life in Patients with Moderate-to-Severe Acne Vulgaris

People with moderate-to-severe acne reported better quality of life after 12 weeks of treatment with tretinoin 0.05% lotion, and clinical improvements in acne symptoms may have contributed to these outcomes.

Awareness on Teratogenic Effects of Isotretinoin and Compliance with Precautionary Measures among Women of Childbearing Age in Makkah Province, Saudi Arabia

Evaluation of the awareness of women of childbearing age in Makkah Province, Saudi Arabia with regards to the side effects of isotretinoin use, specifically its teratogenicity shows a need for improvement when it comes to compliance of both doctors and patients.

Efficacy and tolerability of low‐dose spironolactone and topical benzoyl peroxide in adult female acne: A randomized, double‐blind, placebo‐controlled trial

The combination of SPL 50 mg/day and topical BP proved effective in improving moderate AFA in Thai women, with an acceptable side‐effect profile.

Stem cell membrane-coated isotretinoin for acne treatment

STCM-ATRA-NPs were demonstrated to control isotretinoin release, reducing its side effects, and efficiently permeating through the skin by reducing the effect of keratin and tight junction proteins and enhancing endocytosis.



Oral spironolactone: an effective treatment for acne vulgaris in women

Initial plasma androgen levels were no higher in responders than in non‐responders, nor did oral contraceptive use appear to affect clinical response, and spironolactone is a useful alternative therapy for women with acne vulgaris.

Hematologic safety of dapsone gel, 5%, for topical treatment of acne vulgaris.

After treatment with dapsone gel, 5%, no clinical or laboratory evidence of drug-induced hemolytic anemia was noted in G6PD-deficient subjects with acne vulgaris.

Moderate and Severe Inflammatory Acne Vulgaris Effectively Treated with Single-Agent Therapy by a New Fixed-Dose Combination Adapalene 0.3 %/Benzoyl Peroxide 2.5 % Gel: A Randomized, Double-Blind, Parallel-Group, Controlled Study

Results of this clinical trial demonstrate the significantly greater efficacy of adapalene 0.3 % A/BPO topical gel compared with vehicle as well as a good safety profile in the treatment of moderate to severe inflammatory non-nodulocystic acne, which increases patients’ treatment options.

The Efficacy and Safety of Topical Dapsone Gel, 5% for the Treatment of Acne Vulgaris in Adult Females With Skin of Color.

Monotherapy with dapsone gel, 5% administered twice daily was safe and effective for treatment of facial acne in women with SOC and study subjects reported considerable improvement in both acne signs and impact on QOL.

Comparative efficacy and tolerability of dapsone 5% gel in adult versus adolescent females with acne vulgaris.

Dapsone 5% gel twice daily is effective in reducing inflammatory and noninflammatory acne vulgaris lesions in both adolescent and adult women, and is safe in these subgroups.

Adult female acne treated with spironolactone: a retrospective data review of 70 cases

This retrospective data analysis confirms that the use of low doses of spironolactone is a valuable alternative in women with acne in whom oral isotretinoin has failed, and shows that first and second-generation oral contraceptives decrease the efficacy of the drug.

Cohort study on the treatment with dapsone 5% gel of mild to moderate inflammatory acne of the face in women.

Topical dapsone 5% gel 5% was shown to be safe, minimally irritating, and effective in the treatment of mild to moderate inflammatory facial acne in adult women with sensitive skin.

Effective and safe combination therapy for severe acne vulgaris: a randomized, vehicle-controlled, double-blind study of adapalene 0.1%-benzoyl peroxide 2.5% fixed-dose combination gel with doxycycline hyclate 100 mg.

Evidence is provided on the efficacy of combining A/BPO and the oral antibiotic doxycycline in the treatment of severe acne vulgaris and digital UV fluorescence photography demonstrated a rapid reduction in Propionibacterium acnes in the A/ BPO with doxy cycline group, particularly within the first 4 weeks.

Expert Committee Recommendations for Acne Management

It is recommended that acne treatments should be combined to target as many pathogenic factors as possible and Oral antibiotics should be used only in moderate-to-severe acne, should not be used as monotherapy, and should be discontinued as soon as possible.